BALPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > balpharma

Technical Analysis

Technical Strength: 3.7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 48.1. According to RSI analysis, balpharma is marginally weak. 4.0 BALPHARMA RSI Chart
MACD (?) MACD: -0.355 and Signal Line: -0.445. According to MACD analysis, balpharma is marginally strong. 7.0 BALPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, balpharma is in a downtrend. Resistance level is at 95.1. 1.0 BALPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, balpharma is in a strong downtrend. Major resistance levels are 94.68513, 95.54399, 96.0352. 0.0 BALPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.423. 5.0 BALPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 99.7028 and 102.7. Support level is 90.0. 2.5 BALPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 3.19 NA BALPHARMA Average True Range Chart
Average Directional Index (?) ADX is 6.85 which means BALPHARMA is in a trading range and there is no trend. NA BALPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
October 17, 2017
Open Price 95.0
High Price 95.0
Low Price 94.0
Close Price 94.35
Absolute Change 0.2
Percentage Change 0.212%
Weekly Change 0.319%
Monthly Change 0.212%
Yearly Change -13.8%
52-week high 121.15
52-week low 83.95
Corporate Actions
ExDate Purpose
September 14, 2017 AGM/DIV-RE 1 PER SHARE
September 15, 2016 AGM/DIV RE 1/- PER SHARE
September 12, 2013 AGM/DIV-RE 0.75 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.746
Confidence in Beta2.4%
Market Capital Rs. 121.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 3.11
TTM Price-to-Earnings (P/E) Ratio 30.3
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 17 October 2017: Deliverable Quantity:0 NA BALPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 16 October 2017: Daily Volatility:0.3496 NA BALPHARMA Annualized Daily Volatility (Spot Price) Chart


September 25, 2017 BShareholders meetingBal Pharma Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 22, 2017. Further, the company has informed the Exchange regarding voting results.
September 22, 2017 BShareholders meetingBal Pharma Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 22, 2017
See all Announcements

Board Meetings

Date Meeting Date Purpose
August 30, 2017 September 11, 2017 IResultsInter alia will be considering approval of Ind-AS compliant, un-audited stand alone and consolidated financial results of the Company for the quarter ended June 30, 2017.
July 31, 2017 August 10, 2017 iOthersinter alia will be transacting the following business. 1.To approve the 30th Annual General Meeting Notice (AGM), Directors Report and Corporate Governance reports of the Company, for the financial year ended March 31, 2017. 2. To decided on the Book closure dates. 3. To consider other AGM related matters
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 92.9 Rs. 93.45 Rs. 93.9 Rs. 94.45 Rs. 94.9 Rs. 95.45 Rs. 95.9